We measured serum phospholipase A2 (PLA2) activity in 39 schizophrenic
s, 26 psychiatric controls, and 26 normal controls using a radioenzyma
tic assay with phosphatidylcholine as precursor. Serum PLA2 activity w
as significantly higher in schizophrenics (p = 0.002) and other psychi
atric (including substance abusing) patients (p = 0.032) than in norma
l controls. Enzyme activity did not differ between the schizophrenic p
atients and psychiatric controls. Fifty-one percent of the schizophren
ics and 46% of psychiatric controls had PLA2 values above the highest
value for normal controls. In the psychiatric control group higher tha
n normal PLA2 activities were observed in all diagnostic categories, i
ncluding major depression, bipolar disorder, posttraumatic stress diso
rder (PTSD), and substance abuse. In the context of others' findings o
f increased circulating PLA2 in infectious and inflammatory conditions
, these increases must be viewed as disease nonspecific. The significa
nce of these changes and their relationship to other acute-phase prote
in changes needs to be clarified in future research.